The effect of renal phosphate clearance on serum fibroblats growth factor 23 (FGF23) in patients on peritonela dialysis

The effect of renal phosphate clearance on serum fibroblats growth factor 23 (FGF23) in patients on peritonela dialysis - The effect of renal phosphate clearance on serum fibroblats growth factor 23 (FGF23) in patients on peritonela dialysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009315

Enrollment

Registered

2012-11-13

Start date

2012-11-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endstage renal disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients on peritoneal dialysis at Kyushu University Hospital who received serum FGF23 determination between June 2010 and June 2012

Exclusion criteria

Exclusion criteria: Patients who did receive peritoneal dialysis thearapy more than 30 days

Design outcomes

Primary

Measure	Time frame
Serum fibrobast growth factor 23 (FGF23) concentration	—

Countries

Japan

Contacts

Public ContactShunsuke Yamada

Kyushu University Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences

ana65641@nifty.com092-642-5843

Outcome results